Sangamo Therapeutics
SGMO
#8725
Rank
โ‚น14.99 B
Marketcap
โ‚น44.55
Share price
-6.45%
Change (1 day)
-73.30%
Change (1 year)

Sangamo Therapeutics (SGMO) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : โ‚น7.40 Billion

According to Sangamo Therapeutics 's latest financial reports the company's total liabilities are โ‚น7.40 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Sangamo Therapeutics - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31โ‚น6.76 B-1.41%
2023-12-31โ‚น6.86 B-69%
2022-12-31โ‚น22.13 B-14.17%
2021-12-31โ‚น25.79 B-20.05%
2020-12-31โ‚น32.26 B120.95%
2019-12-31โ‚น14.60 B-6.41%
2018-12-31โ‚น15.60 B147.22%
2017-12-31โ‚น6.31 B328.06%
2016-12-31โ‚น1.47 B-10.53%
2015-12-31โ‚น1.64 B-28.92%
2014-12-31โ‚น2.31 B96.18%
2013-12-31โ‚น1.18 B22.37%
2012-12-31โ‚น0.96 B153.4%
2011-12-31โ‚น0.38 B19.92%
2010-12-31โ‚น0.31 B-56.26%
2009-12-31โ‚น0.72 B21.36%
2008-12-31โ‚น0.59 B29.5%
2007-12-31โ‚น0.46 B47.51%
2006-12-31โ‚น0.31 B-37.65%
2005-12-31โ‚น0.50 B394.27%
2004-12-31โ‚น0.10 B42.16%
2003-12-31โ‚น71.52 M-24.71%
2002-12-31โ‚น94.99 M-26.21%
2001-12-31โ‚น0.12 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Gilead Sciences
GILD
โ‚น3.330 T 44,896.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚น414.84 B 5,504.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น7.233 T 97,620.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚น988.20 B 13,249.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
โ‚น3.766 T 50,781.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚น10.199 T 137,690.05%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚น139.97 B 1,790.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น6.974 T 94,122.09%๐Ÿ‡บ๐Ÿ‡ธ USA